PE20010029A1 - Androgenos oralmente activos - Google Patents

Androgenos oralmente activos

Info

Publication number
PE20010029A1
PE20010029A1 PE2000000309A PE0003092000A PE20010029A1 PE 20010029 A1 PE20010029 A1 PE 20010029A1 PE 2000000309 A PE2000000309 A PE 2000000309A PE 0003092000 A PE0003092000 A PE 0003092000A PE 20010029 A1 PE20010029 A1 PE 20010029A1
Authority
PE
Peru
Prior art keywords
orally active
alkyl
hydrogen
active androgens
acyl
Prior art date
Application number
PE2000000309A
Other languages
English (en)
Spanish (es)
Inventor
Dirk Leysen
Der Louw Jaap Van
Bursi Roberta Buma
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20010029A1 publication Critical patent/PE20010029A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PE2000000309A 1999-04-06 2000-04-06 Androgenos oralmente activos PE20010029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201070 1999-04-06

Publications (1)

Publication Number Publication Date
PE20010029A1 true PE20010029A1 (es) 2001-01-26

Family

ID=8240066

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000309A PE20010029A1 (es) 1999-04-06 2000-04-06 Androgenos oralmente activos

Country Status (10)

Country Link
US (2) US6756366B1 (enExample)
EP (1) EP1212345B1 (enExample)
JP (1) JP2002541153A (enExample)
AT (1) ATE246703T1 (enExample)
AU (1) AU5209600A (enExample)
CO (1) CO5160345A1 (enExample)
DE (1) DE60004377T2 (enExample)
ES (1) ES2204613T3 (enExample)
PE (1) PE20010029A1 (enExample)
WO (1) WO2000059920A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
AU2003205604B8 (en) * 2002-01-21 2009-12-24 Merck Sharp & Dohme B.V. Process for the preparation of 7alpha-methylsteroids
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
KR101602802B1 (ko) * 2008-04-09 2016-03-11 페린 파마슈티칼즈, 인코포레이티드 고열 홍조에 대한 스테로이드 치료
EP2667876A2 (en) * 2010-12-15 2013-12-04 Harbor BioSciences, Inc. Methods and compounds for preparing 3alpha-oxygen substituted steroids

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755689A (fr) * 1969-09-03 1971-03-03 Upjohn Co Procede de fabrication de nouvelles 7 beta-alkyl-19- nortestosterones
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE69418744T2 (de) * 1993-03-05 1999-11-11 Akzo Nobel N.V., Arnheim/Arnhem Verwendung von Pregnanderivaten zur Behandlung von Tumoren
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical compositions containing desogestrel their preparation and use
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
PT833642E (pt) * 1995-06-22 2002-08-30 Akzo Nobel Nv Comprimidos de desogestrel prensados por granulacao a seco
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
IL119468A (en) * 1995-11-06 2000-02-29 Akzo Nobel Nv Method of isomerisation of equilin or derivatives thereof
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
CA2200423C (en) * 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
ATE215555T1 (de) * 1997-06-04 2002-04-15 Akzo Nobel Nv 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
DK0927556T3 (da) * 1997-09-23 2000-11-20 Akzo Nobel Nv Coatede dosisenheder
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
HUP0100542A3 (en) * 1997-11-14 2001-10-29 Akzo Nobel Nv Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
ATE220686T1 (de) * 1997-12-18 2002-08-15 Akzo Nobel Nv 17beta-aryl(arylmethyl)oxy(thio)alkyl- androstanderivative
JP4422331B2 (ja) * 1998-02-26 2010-02-24 ナームローゼ・フエンノートチヤツプ・オルガノン アゼチジン誘導体およびピロリジン誘導体
AU756739B2 (en) * 1998-06-19 2003-01-23 N.V. Organon Testosterone derivative
US6528501B1 (en) * 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
US6498153B1 (en) * 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
JP2002539134A (ja) * 1999-03-09 2002-11-19 アクゾ・ノベル・エヌ・ベー 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
KR20020092907A (ko) * 1999-09-06 2002-12-12 악조 노벨 엔.브이. 11번 위치에 탄화수소 치환기를 보유한 비방향족에스트로겐 스테로이드
SK287095B6 (sk) * 1999-12-02 2009-12-07 N.V. Organon Androgénové zlúčeniny, použitie androgénových zlúčenín a súprava s ich obsahom
ATE374752T1 (de) * 2000-03-27 2007-10-15 Organon Nv Nicht-steroidale tetracyclische verbindungen für östrogen-verwandte behandlungen
JP2004506712A (ja) * 2000-08-23 2004-03-04 アクゾ・ノベル・エヌ・ベー 医療に使用するための１０−アリール−１１Ｈ−ベンゾ［ｂ］フルオレン誘導体および類似体

Also Published As

Publication number Publication date
WO2000059920A3 (en) 2001-02-15
CO5160345A1 (es) 2002-05-30
ES2204613T3 (es) 2004-05-01
EP1212345B1 (en) 2003-08-06
DE60004377D1 (de) 2003-09-11
DE60004377T2 (de) 2004-06-09
JP2002541153A (ja) 2002-12-03
WO2000059920A2 (en) 2000-10-12
AU5209600A (en) 2000-10-23
US6756366B1 (en) 2004-06-29
EP1212345A2 (en) 2002-06-12
US20040209853A1 (en) 2004-10-21
ATE246703T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
NZ516525A (en) Orally active androgens
NL300877I2 (nl) obeticholzuur
DK0931788T3 (da) Metalloproteasehæmmere
DK1177176T3 (da) Triarylsyrederivater som PPAR-receptorligander
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
MY116074A (en) Oxime derivatives and the use thereof as latent acids
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
MY129796A (en) Novel anti-inflammatory androstane derivatives
CO5611139A2 (es) Pirimidinas aril sustituidas y el uso de las mismas
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
NO20022976L (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
PE20010029A1 (es) Androgenos oralmente activos
ATE259813T1 (de) Triazolopyrimidinderivate
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
IT1317031B1 (it) Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
WO2003024913A1 (en) SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY
EA200401099A1 (ru) Производные гетероциклического амида
UY26416A1 (es) Compuestos
NO20031046D0 (no) Fremgangsmåte for fremstilling av en substituert imidazopyridinforbindelse
DE60006029D1 (de) 1-Aza-2-alkyl-6-aryl-cycloalkanen zur Verbesserung des Gedächtnisses
ATE457023T1 (de) Alkylpyridiniumdicyanamide als polare lösungsmittel
NO20025101L (no) Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet
DE60319743D1 (de) Phthalazinderivate als phosphodiesterase-4-hemmer
ECSP003416A (es) Nuevos androgenos oralmente activos derivados de 7beta- metil-19- nortestosterona

Legal Events

Date Code Title Description
FC Refusal